MaxCyte, Inc. Payment for Debt Extinguishment or Debt Prepayment Cost
MaxCyte, Inc. (MXCT) reported Payment for Debt Extinguishment or Debt Prepayment Cost of $260.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtExtinguishmentCosts · last filed 2023-03-15
- MaxCyte, Inc. payment for debt extinguishment or debt prepayment cost for the quarter ending 2021-03-31 was $260.00K.
| Period end | Payment for Debt Extinguishment or Debt Prepayment Cost | Payment for Debt Extinguishment or Debt Prepayment Cost 1 month | Payment for Debt Extinguishment or Debt Prepayment Cost 3 month |
|---|---|---|---|
| 2021-03-31 | $260.00K 10-K · filed 2022-03-22 | $260.00K 10-K · filed 2023-03-15 | $260.00K 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |